J Chang1, A E Hakam1, L K McCauley2,3. 1. Department of Periodontology, University of Florida College of Dentistry, Gainesville, FL, 32610, USA. 2. Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, 1011 North University Ave, Ann Arbor, MI, 48109, USA. mccauley@umich.edu. 3. Department of Pathology, Medical School, University of Michigan, Ann Arbor, MI, USA. mccauley@umich.edu.
Abstract
PURPOSE OF REVIEW: Osteonecrosis of the jaw (ONJ) is a rare and severe necrotic bone disease reflecting a compromise in the body's osseous healing mechanisms and unique to the craniofacial region. Antiresorptive and antiangiogenic medications have been suggested to be associated with the occurrence of ONJ; yet, the pathophysiology of this disease has not been fully elucidated. This article raises the current theories underlying the pathophysiology of ONJ. RECENT FINDINGS: The proposed mechanisms highlight the unique localization of ONJ. The evidence-based mechanisms of ONJ pathogenesis include disturbed bone remodeling, inflammation or infection, altered immunity, soft tissue toxicity, and angiogenesis inhibition. The role of dental infections and the oral microbiome is central to ONJ, and systemic conditions such as rheumatoid arthritis and diabetes mellitus contribute through their impact on immune resiliency. Current experimental studies on mechanisms of ONJ are summarized. The definitive pathophysiology is as yet unclear. Recent studies are beginning to clarify the relative importance of the proposed mechanisms. A better understanding of osteoimmunology and the relationship of angiogenesis to the development of ONJ is needed along with detailed studies of the impact of drug holidays on the clinical condition of ONJ.
PURPOSE OF REVIEW: Osteonecrosis of the jaw (ONJ) is a rare and severe necrotic bone disease reflecting a compromise in the body's osseous healing mechanisms and unique to the craniofacial region. Antiresorptive and antiangiogenic medications have been suggested to be associated with the occurrence of ONJ; yet, the pathophysiology of this disease has not been fully elucidated. This article raises the current theories underlying the pathophysiology of ONJ. RECENT FINDINGS: The proposed mechanisms highlight the unique localization of ONJ. The evidence-based mechanisms of ONJ pathogenesis include disturbed bone remodeling, inflammation or infection, altered immunity, soft tissue toxicity, and angiogenesis inhibition. The role of dental infections and the oral microbiome is central to ONJ, and systemic conditions such as rheumatoid arthritis and diabetes mellitus contribute through their impact on immune resiliency. Current experimental studies on mechanisms of ONJ are summarized. The definitive pathophysiology is as yet unclear. Recent studies are beginning to clarify the relative importance of the proposed mechanisms. A better understanding of osteoimmunology and the relationship of angiogenesis to the development of ONJ is needed along with detailed studies of the impact of drug holidays on the clinical condition of ONJ.
Entities:
Keywords:
Anti-angiogenesis; Bone remodeling; Immunity; Inflammation; Oral infection; Osteonecrosis of the jaw
Authors: E J Ohlrich; D E Coates; M P Cullinan; T J Milne; S Zafar; Y Zhao; W D Duncan; G J Seymour Journal: Arch Oral Biol Date: 2015-11-23 Impact factor: 2.633
Authors: Drake W Williams; Cindy Lee; Terresa Kim; Hideo Yagita; Hongkun Wu; Sil Park; Paul Yang; Honghu Liu; Songtao Shi; Ki-Hyuk Shin; Mo K Kang; No-Hee Park; Reuben H Kim Journal: Am J Pathol Date: 2014-08-28 Impact factor: 4.307
Authors: Furqan A Shah; Bryan E J Lee; James Tedesco; Cecilia Larsson Wexell; Cecilia Persson; Peter Thomsen; Kathryn Grandfield; Anders Palmquist Journal: Nano Lett Date: 2017-09-18 Impact factor: 11.189
Authors: Christoph Pautke; Kilian Kreutzer; Jochen Weitz; Martina Knödler; Daniela Münzel; Gabriele Wexel; Sven Otto; Alexander Hapfelmeier; Stephen Stürzenbaum; Thomas Tischer Journal: Bone Date: 2012-05-07 Impact factor: 4.398
Authors: Lawrence Drudge-Coates; Tim Van den Wyngaert; Morten Schiødt; H A M van Muilekom; Gaston Demonty; Sven Otto Journal: Support Care Cancer Date: 2020-04-19 Impact factor: 3.603